Medtronic taps Lennon as CIO | Personnel Moves – April 9, 2018

Medtronic CIO Sean Lennon

Medtronic (NYSE:MDT) said that it named Sean Lennon as its new chief information officer, set to take effect April 29.

The Fridley, Minn.-based medtech giant said that Lennon will take over for Mike Hedges, who is retiring from the position after 19 years with Medtronic, including 10 as CIO.

Prior to joining Medtronic, Lennon served as CIO with Allergan (NYSE: AGN), the company said. He has previously held senior leadership positions with pharmaceutical companies including Watson/Actavis, Novartis (NYSE:NVS) and Schering-Plough.

 Clearside Biomedical appoints Lasezkay as interim CEO

Clearside Biomedical (NSDQ:CLSD) said yesterday that it named George Lasezkay as its new interim CEO, effective immediately.

Lasezkay will succeed Daniel White, who resigned as prez, CEO and as a board member to pursue other opportunities, the Alpharetta, Ga.-based company said.

Prior to joining Clearside, Lasezkay acted as exec VP and GC for novel ophthalmic therapeutics maker Acucela and as prez of Horizon Pharma Group. He has also acted as corporate dev corp VP for Allergan, the company said.

“We believe there is tremendous potential in our proprietary suprachoroidal space injection platform, as evidenced by the acceptance of our new drug application for Xipere for suprachoroidal injection. We want to thank Daniel for his visionary contributions, including licensing the original scientific technology, building our versatile therapeutic platform, leading our IPO and other financings, and hiring an experienced team to bring these important innovative products to market. We are at an important stage in the evolution of our company, so we are pleased to have Dr. George Lasezkayserve as CEO on an interim basis as we conduct a search for our next CEO. George has broad expertise in ophthalmology established during his tenure at Allergan, Inc., where he served on the company’s executive committee. With proven management experience and substantial industry knowledge, we believe George will help lead our team as we prepare for commercialization of our first product and look to leverage our unique platform through pipeline expansion and partnerships. We expect to benefit from his combination of clinical, legal, business development and executive expertise, and his diverse experience working with a number of emerging biopharmaceutical companies,” board chair William Humphries said in a press release.

Clearside Biomedical said that it is initiating a search for a permanent replacement.

“We are excited about our suprachoroidal drug delivery platform and potential approval of our first agent for the treatment of macular edema associated with uveitis, which would be a significant milestone for Clearside. We also believe the platform has broad applicability in other eye diseases and continue to explore utilizing suprachoroidal administration with other small molecules and gene therapy. I am confident in the capabilities of the Clearside team and look forward to working with them to ensure the long-term success of Xipere, prudently build our ophthalmic pipeline, and work with potential partners to leverage our platform and provide international reach,” Lasezkay said in a prepared statement.

Read more

 SynCardia Systems promotes COO Webber to CEO

SynCardia Systems said last week that it promoted current chief operating officer Don Webber to CEO, and that it tapped Peter Spadaro as its new prez & CCO.

Prior to joining Syncardia last year as COO, Webber served as COO at OptiScan and held a manufacturing operations VP position with C.R. Bard, an operations VP position with Ekos and as prez & CEO of Mitralign, Tuscon, Ariz.-based SynCardia said.

Before taking the position with SynCardia, Spadaro held a position as cardiac surgery senior sales director at Medtronic, after having spent nearly 30 years with St. Jude Medical, the company said in a press release.

Read more

 iHear Medical names Shennib as CEO

iHear Medical said last week that it named founder & board chair Adnan Shennib as its new CEO.

The San Leandro, Calif.-based company said that Shennib had spent more than 30 years of experience in founding and leading hearing tech companies, including ReSound and InSound Medical.

iHear Medical also said that Varun Bhardwaj joined the company as operations VP, having previously held the position of chief innovation officer.

Read more

 LumeNXT names co-founder Rhyne as CEO

Surgical device maker LumeNXT said last week that it named co-founder Paul Rhyne as its new CEO.

Prior to co-founding Boston-based LumeNXT, Rhyne spent time with Intarcia Therapeutics, the company said. Rhyne also spent 11 years at Coloplast Corp., holding positions including Canadian country manager.

“We are proud to name Paul as CEO here at LumeNXT. His wealth of experience and insight into the interaction between the commercial business sector and healthcare space is valuable during this growth stage in our company,” board chair Marc Beer said in a press release.

Read more

Owens & Minor inks distribution deal with Scripps Health

Owens-MinorOwens & Minor (Mechanicsville, Va.) has signed a five-year medical and surgical supply distribution agreement with Scripps Health. The financial details of the deal were not disclosed.

Scripps Health is a California-based healthcare system that treats more than 750,000 patients annually. Under the agreement, Owens & Minor will serve Scripps Health’s five acute-care hospital campuses and the non-acute care, outpatient centers and clinics in Southern California.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Owens & Minor inks distribution deal with Scripps Health appeared first on MassDevice.

Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018

Google Health CEO David Feinberg

Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report.

The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other candidates include execs from health consulting, hospital management and insurance.

In his new position, Feinberg will work closely with CEO Sundar Pichai, according to CNBC, which references individuals familiar with the search process.

Feinberg will oversee multiple groups at Google interested in healthcare including its core search team, cloud business and Google Brain AI team, according to the report.

The formerly independent Alphabet DeepMind health and AI company will also merge back into Google under the newly formed Google health team, according to a separate CNBC report.

Feinberg will be looking to organize the healthcare efforts at the tech giant, including building a health team within Google’s Nest automated home division, which was also merged back into the Google Home team this year, that could help monitor seniors living independently, according to the report.

No information has emerged as to whether Feinberg will work hand-in-hand with other Alphabet healthcare plays, including Verily.

Google has not yet officially commented on the hiring.

 Owens & Minor names Sledd as interim prez & CEO, begins search for perm replacement

Owens & Minor (NYSE:OMI) said last week that it named board member Robert Sledd as its new board chair and interim prez & CEO, succeeding P. Phipps.

The Richmond, Va.-based company said that it has formed a search committee, which will be assisted by an executive search firm, as it looks for a permanent replacement for the departed Phipps.

Sledd has served as a board member since 2007 and previously spent more than 20 years as chairman and CEO of food distro company Performance Food Group, which he co-founded in 1987. He also recently served as managing partner at Pinnacle Ventures and Sledd Properties, and prior to that served as a Senior Economic Advisor to the former Governor of Virginia.

“The board believes the business will benefit from a change in leadership. We thank Cody for his contributions to Owens & Minor and appreciate Bob Sledd’s willingness to step in on an interim basis as we conduct a search for our next CEO. Bob has a long and successful track record operating a large distribution company. We will benefit from his wealth of management experience as well as his knowledge of our business from his board tenure. Under Bob’s leadership, we will continue to execute on our strategic plan to strengthen and diversify our business as we also focus on operational excellence,” lead director Anne Whittemore said in a prepared statement.

“Owens & Minor is a highly respected company that is well positioned to address the critical supply chain needs of providers and manufacturers across the continuum of care. I look forward to working with our dedicated teammates to provide our customers with services and products that improve healthcare delivery,” Sledd said.

In addition to Sledd taking over as interim CEO, the company said that its current interim CFO Robert Snead will continue in his position.

“Robert is an outstanding teammate and I look forward to working closely with him,” Sledd said.

Read more

 EOS Imaging taps NA prez Lobinsky as CEO

EOS Imaging (EPA:EOSI) said last week that it has picked NA prez Mike Lobinsky as its new CEO, taking over for Marie Meynadier who will step away from the position at the beginning of the new year, but will retain a board seat.

The move comes as the Paris, France-based company looks to strengthen its presence in the US and to expand its shareholder base, EOS Imaging said.

Lobinsky’s election was unanimously decided by the company’s board of directors, EOS Imaging said. He has held leadership positions with Smith & Nephew (NYSE:SNN), Brainlab, Blue Belt Technologies  and Stryker (NYSE:SYK), the company added.

EOS Imaging said that it also added Valérie Worrall as its new CFO. Worrall has previously served as CFO of medical device company Balt.

“I have enjoyed working with Mike for over a year. His leadership and knowledge of the industry, combined with his fine understanding of corporate culture, are excellent assets for EOS imaging and I have complete confidence in his ability to continue and accelerate the development of the company. Our North American market is considerable, and Mike will be able to develop it without denying our European roots, relying on the talented management team present in Paris, particularly Eric Maulavé, chief operating officer, to continue to drive global growth. It was an honor and a great pleasure to serve the company and to develop it since its foundation. I am most grateful to the men and women within our staff, to our directors, shareholders and clinical partners, who contributed to this development over these last years. Our teams can be proud of the work accomplished, and I have full confidence that they will continue to build our success under Mike’s leadership,” Meynadier said in a press release.

“Marie’s vision, her energy and her remarkable managerial talent have brought EOS imaging to a stage of excellence and a unique international reputation. Marie has given the company access today to an acceleration opportunity in the United States, which is a new step. She has managed to attract a management team capable of taking up this new challenge and ensure a successful succession. It is rare to be able to apprehend the future in such optimism,” board chair Gérard Hascoet said in a prepared statement.

“I am very grateful to Marie and the board members for their trust and pleased to accept the CEO position. Few companies have accomplished what EOS has and these achievements have established a strong foundation for further development. The potential of our entire solution is outstanding, and I am confident in our ability to translate this into growth and value in the short, medium, and long terms,” Lobinsky said in a prepared release.

Read more

 Bovie Medical CFO Ewers to retire

Bovie Medical (NYSE:BVX) said this week that its chief financial officer, treasurer and secretary Jay Ewers intends to retire.

The Clearwater, Fla.-based company said that it has launched a search for a replacement and that Ewers will stay with the company until a successor is found, after which he will aid in the transition process.

“I would like to thank Jay, on behalf of the board and the entire team at Bovie Medical, for his significant contributions since joining the company in 2014. We appreciate his continued commitment to the company and its shareholders as we identify a successor and wish him the very best in his future endeavors,” prez & CEO Charlie Goodwin said in a prepared statement.

“It has been a great pleasure to serve on the executive leadership team at Bovie Medical and I’m proud of our many accomplishments during my tenure. With the proceeds from the recent strategic transaction, Bovie Medical is in a strong financial position to pursue its future growth objectives, and I believe this was the right time to begin my transition to retirement,” Ewers said in a press release.

Read more

 Procept BioRobotics appoints Waters as CFO

Procept BioRobotics said last week it appointed former Accuray (NSDQ:ARAY)  chief financial officer Kevin Waters as its new CFO.

Prior to joining Accuray, Waters held financial leadership positions with a number of medical device companies including Conceptus, Laserscope and Visx. He has also held positions at PricewaterhouseCoopers, the Redwood Shores, Calif.-based company said.

“Kevin’s deep industry knowledge and leadership experience in commercial stage organizations make him a valuable addition to the Procept team, as we drive towards making Aquablation therapy with the Aquabeam robotic system the standard of care for treating BPH. His appointment rounds out the executive team at Procept, well-positioning the company for strong growth ahead,” founder & CEO Nikolai Aljuri said in a press release.

Read more

The post Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018 appeared first on MassDevice.